Trial NCT01334710

View at ClinicalTrials.gov 
Org. Study IDs: IRB00047003
Secondary IDs: WCI1887-10

Last trial update was posted on 2017-11-21

MeSH Interventions

Sorafenib

MeSH Conditions

Carcinoma, Hepatocellular Liver Neoplasms

Other Conditions

Liver Cancer

Stopping Reasons

safety issue observed on another hepatocellular study using OSI906

Limitations And Caveats

A second trial evaluating OSI906 in hepatocellular cancer was being run in parallel to this trial. There were safety signals in the second trial which led to stopping this trial.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID